Neuren Pharmaceuticals
NEU.AX
#5011
Rank
HK$13.50 B
Marketcap
HK$106.65
Share price
6.06%
Change (1 day)
85.38%
Change (1 year)

Earnings for Neuren Pharmaceuticals (NEU.AX)

Earnings in 2024: HK$0.88 Billion

According to Neuren Pharmaceuticals's latest financial reports the company's current earnings are HK$0.13 Billion. In 2024 the company made an earning of HK$0.88 Billion a decrease over its 2023 earnings that were of HK$1.08 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neuren Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024HK$0.88 B-18.58%
2023HK$1.08 B111519.63%
2022HK$0.97 M-102.22%
2021-HK$44.06 Million-20.06%
2020-HK$55.12 Million-6.65%
2019-HK$59.05 Million-449.8%
2018HK$16.87 M-213.69%
2017-HK$14.85 Million-80.94%
2016-HK$77.89 Million-3.07%
2015-HK$80.35 Million51.42%
2014-HK$53.07 Million-32.7%
2013-HK$78.84 Million87.47%
2012-HK$42.06 Million10.96%
2011-HK$37.91 Million-4.11%
2010-HK$39.53 Million21025.61%
2009-HK$0.19 Million-99.78%
2008-HK$84.49 Million1.99%
2007-HK$82.84 Million33.24%
2006-HK$62.18 Million31.45%
2005-HK$47.3 Million37.67%
2004-HK$34.36 Million4.98%
2003-HK$32.73 Million36.5%
2002-HK$23.98 Million